| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Howard Hughes Medical Institute,
Rheumatology Division, Department of Medicine, and
Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110
Inhibitory receptors on hemopoietic cells critically regulate cellular function. Despite their expression on a variety of cell types, these inhibitory receptors signal through a common mechanism involving tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif (ITIM), which engages Src homology 2 (SH2) domain-containing cytoplasmic tyrosine or inositol phosphatases. In this study, we have investigated the proximal signal-transduction pathway of an ITIM-bearing receptor, gp49B, a member of a newly described family of murine NK and mast cell receptors. We demonstrate that the tyrosine residues within the ITIMs are phosphorylated and serve for the association and activation of the cytoplasmic tyrosine phosphatase SHP-1. Furthermore, we demonstrate a physiologic association between gp49B and SHP-1 by coimmunoprecipitation studies from NK cells. To address the mechanism of binding between gp49B and SHP-1, binding studies involving glutathione S-transferase SHP-1 mutants were performed. Utilizing the tandem SH2 domains of SHP-1, we show that either SH2 domain can interact with phosphorylated gp49B. Full-length SHP-1, with an inactivated amino SH2 domain, also retained gp49B binding. However, binding to gp49B was disrupted by inactivation of the carboxyl SH2 domain of full-length SHP-1, suggesting that in the presence of the phosphatase domain, the carboxyl SH2 domain is required for the recruitment of phosphorylated gp49B. Thus, gp49B signaling involves SHP-1, and this association is dependent on tyrosine phosphorylation of the gp49B ITIMs, and an intact SHP-1 carboxyl SH2 domain.
This article has been cited by other articles:
|
|
 |
|
  K. Oishi, K. Gaengel, S. Krishnamoorthy, K. Kamiya, I.-K. Kim, H. Ying, U. Weber, L. A. Perkins, M. Tartaglia, M. Mlodzik, et al. Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations Hum. Mol. Genet., February 15, 2006; 15(4): 543 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Young, X. Zheng, D. Holowka, and B. Baird Reconstitution of Regulated Phosphorylation of Fc{epsilon}RI by a Lipid Raft-excluded Protein-tyrosine Phosphatase J. Biol. Chem., January 14, 2005; 280(2): 1230 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Lin, S. Raval, Z. Zhang, M. Deverill, K. A. Siminovitch, D. R. Branch, and B. Haimovich The Protein-tyrosine Phosphatase SHP-1 Regulates the Phosphorylation of {alpha}-Actinin J. Biol. Chem., June 11, 2004; 279(24): 25755 - 25764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yang, L. Liu, D. He, X. Song, X. Liang, Z. J. Zhao, and G. W. Zhou Crystal Structure of Human Protein-tyrosine Phosphatase SHP-1 J. Biol. Chem., February 14, 2003; 278(8): 6516 - 6520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nandan, T. Yi, M. Lopez, C. Lai, and N. E. Reiner Leishmania EF-1alpha Activates the Src Homology 2 Domain Containing Tyrosine Phosphatase SHP-1 Leading to Macrophage Deactivation J. Biol. Chem., December 13, 2002; 277(51): 50190 - 50197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Oka, M. Ouchida, M. Koyama, Y. Ogama, S. Takada, Y. Nakatani, T. Tanaka, T. Yoshino, K. Hayashi, N. Ohara, et al. Gene Silencing of the Tyrosine Phosphatase SHP1 Gene by Aberrant Methylation in Leukemias/Lymphomas Cancer Res., November 15, 2002; 62(22): 6390 - 6394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Ho, L. N. Carayannopoulos, J. Poursine-Laurent, J. Kinder, B. Plougastel, H. R. C. Smith, and W. M. Yokoyama Costimulation of Multiple NK Cell Activation Receptors by NKG2D J. Immunol., October 1, 2002; 169(7): 3667 - 3675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Feng, Y. Sun, and J. G. Douglas Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1 PNAS, September 17, 2002; 99(19): 12049 - 12054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kabat, F. Borrego, A. Brooks, and J. E. Coligan Role That Each NKG2A Immunoreceptor Tyrosine-Based Inhibitory Motif Plays in Mediating the Human CD94/NKG2A Inhibitory Signal J. Immunol., August 15, 2002; 169(4): 1948 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Oka, T. Yoshino, K. Hayashi, N. Ohara, T. Nakanishi, Y. Yamaai, A. Hiraki, C. A. Sogawa, E. Kondo, N. Teramoto, et al. Reduction of Hematopoietic Cell-Specific Tyrosine Phosphatase SHP-1 Gene Expression in Natural Killer Cell Lymphoma and Various Types of Lymphomas/Leukemias : Combination Analysis with cDNA Expression Array and Tissue Microarray Am. J. Pathol., October 1, 2001; 159(4): 1495 - 1505. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Matsumoto, L. L. Wang, W. M. Yokoyama, and T. Aso Uterine Macrophages Express the gp49B Inhibitory Receptor in Midgestation J. Immunol., January 15, 2001; 166(2): 781 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Lee, M. Ono, M. Inui, T. Yuasa, and T. Takai Stimulatory Function of gp49A, a Murine Ig-Like Receptor, in Rat Basophilic Leukemia Cells J. Immunol., November 1, 2000; 165(9): 4970 - 4977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Wang, D. T. Chu, A. O. Dokun, and W. M. Yokoyama Inducible Expression of the gp49B Inhibitory Receptor on NK Cells J. Immunol., May 15, 2000; 164(10): 5215 - 5220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Mousseau, D. Banville, D. L'Abbe, P. Bouchard, and S.-H. Shen PILRalpha , a Novel Immunoreceptor Tyrosine-based Inhibitory Motif-bearing Protein, Recruits SHP-1 upon Tyrosine Phosphorylation and Is Paired with the Truncated Counterpart PILRbeta J. Biol. Chem., February 11, 2000; 275(6): 4467 - 4474. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
